Dr Lal PathLabs Q2 Profit Rises 27 Percent
Dr Lal PathLabs posted a 27 percent increase in second quarter profit driven by higher test volumes and preventive health demand. Consolidated revenue grew nearly 20 percent to 8.74 billion rupees.
Xurve View
洞察:
Xurve View
DR LAL PATHLABS LTD posted a 27% rise in second-quarter net profit to 1.92 billion rupees ($20.27 million) on Wednesday afternoon. The growth in India's diagnostic sector was driven by a 13.6% increase in sample test volumes. The performance highlights ongoing consolidation and rising preventive healthcare adoption across the country.
